• Health & Medicine

News digest – ‘stratified’ medicine, government reforms, and improving survival rates

26 November 2011

• Science & Technology

Cancer Research UK launches nine high-tech gene projects

Unravelling the genetic secrets behind a range of cancers is the aim of a new initiative from Cancer Research UK. Unravelling the genetic secrets behind a range of cancers is the aim of a new initiative from Cancer Research UK.

18 November 2011

• Health & Medicine

Is ecstasy ‘being developed to treat blood cancers’? Not quite…

19 August 2011

New cancer imaging technique uses vitamin C to detect more aggressive tumours

Cancer Research UK scientists have developed a new imaging technique that uses vitamin C to detect cancers likely to be more aggressive or resistant to treatment. Cancer Research UK scientists have developed a new imaging technique that uses vitamin C to detect cancers likely to be more aggressive or resistant to treatment.

3 August 2011

• Science & Technology

Missing DNA 'mechanic' key driver in lymphomas

CANCER RESEARCH UK scientists have discovered how a protein in immune cells plays an essential role in their development by repairing DNA damage - and if this protein is missing lymphomas can form. CANCER RESEARCH UK scientists have discovered how a protein in immune cells plays an essential role in their development by repairing DNA damage - and if this protein is missing lymphomas can form.

17 May 2011

Deprived cancer patients face fatal health problems

Cancer patients from deprived backgrounds are more likely to develop life-threatening health problems, research published today (Wednesday) in the British Journal of Cancer* shows. Cancer patients from deprived backgrounds are more likely to develop life-threatening health problems, research published today (Wednesday) in the British Journal of Cancer* shows.

24 November 2010

• Health & Medicine

Long-term survival from once-deadly cancers doubles

People diagnosed with breast, bowel and ovarian cancers and non-Hodgkin's lymphoma are today twice as likely to survive for at least 10 years as those diagnosed in the early 1970s according to new figures released by Cancer Research UK. People diagnosed with breast, bowel and ovarian cancers and non-Hodgkin's lymphoma are today twice as likely to survive for at least 10 years as those diagnosed in the early 1970s according to new figures released by Cancer Research UK.

12 July 2010

• Health & Medicine
• Science & Technology

Cancer Research UK launches groundbreaking research centre at Barts

A new cancer centre, launched today, puts London at the forefront of cancer research. A new cancer centre, launched today, puts London at the forefront of cancer research.

23 February 2010

• Science & Technology
• Health & Medicine

Deal struck for new investigational anti-cancer drug to target leukaemia and lymphoma

CANCER RESEARCH UK and Cancer Research Technology (CRT), the charityїs development and commercialisation arm, are to undertake a phase I clinical trial of an investigational monoclonal antibody * drug from Merck KGaA, Darmstadt, Germany, called DI-B4 - it is announced today (Monday). CANCER RESEARCH UK and Cancer Research Technology (CRT), the charityїs development and commercialisation arm, are to undertake a phase I clinical trial of an investigational monoclonal antibody * drug from Merck KGaA, Darmstadt, Germany, called DI-B4 - it is announced today (Monday).

4 January 2010

New radioactive drug shows impressive results in early Hodgkin's lymphoma

TWO THIRDS of Hodgkin's lymphoma patients treated with an experimental radioactive cancer therapy responded well to the treatment, reveal the results of a Cancer Research UK phase I trial published in Clinical Cancer Research*, today (Tuesday). TWO THIRDS of Hodgkin's lymphoma patients treated with an experimental radioactive cancer therapy responded well to the treatment, reveal the results of a Cancer Research UK phase I trial published in Clinical Cancer Research*, today (Tuesday).

15 December 2009

• Science & Technology

NCRI Cancer Conference 2009: A new dawn - Monoclonal antibodies

6 November 2009

• Health & Medicine

Manchester scientists take on cancer with pioneering radiotherapy treatment

Manchester scientists are testing an emerging therapy called radioimmunotherapy (RIT) in early phase clinical trials, according to a presentation at the NCRI Cancer Conference in Birmingham today (Wednesday). Manchester scientists are testing an emerging therapy called radioimmunotherapy (RIT) in early phase clinical trials, according to a presentation at the NCRI Cancer Conference in Birmingham today (Wednesday).

8 October 2009